Neurophysiological markers of cue reactivity and inhibition subtend a three-month period of complete alcohol abstinence

Objective: Finding new tools for conventional management of alcohol disorders is a challenge for psychiatrists. Brain indications related to cognitive functioning could represent such an add-on tool. Methods: Forty alcohol-dependent inpatients undertook two cognitive event-related potential (ERP) tasks at the beginning and at the end of a 4-week detoxification program. These comprised a visual oddball task investigating cue reactivity and a Go/No-go task tagging inhibition using oddball P3d and No-go P3d ERP components. Three months after discharge, the patient group (N = 40) was split into two subgroups: patients who remained abstinent during this post-treatment period (90 days; n = 15), and patients who relapsed (mean time: 28.5 ± 26.2 days; n = 25). Pattern changes of both ERP markers (oddball P3d and No-go P3d) during the detoxification were compared to differentiate these populations. Results: Abstinent patients exhibited similar P3d responses devoted to alcohol cues in Sessions 1 and 2, but an increased No-go P3d devoted to No-go trials in alcohol-related contexts in Session 2 compared to Session 1. Conclusions: Specific cue-reactivity and inhibitory neurophysiological markers subtend a further three-months of complete abstinence. Significance: Monitoring these ERP changes during detoxification may provide important clues regarding patients’ future abstinence vs. relapse.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Covid-19 and blood groups: ABO antibody levels may also matter

International audienceBackground : Susceptibility to Covid-19 has been found to be associated with ABO blood group, with O type individuals being at a lower risk. However, the underlying mechanism has not been elucidated. Here, we aimed to test the hypothesis that Covid-19 patients might have lower levels of ABO antibodies than non-infected individuals as they could offer some degree of protection.Methods : After showing that the viral spike protein harbors the ABO glycan epitopes when produced by cells expressing the relevant glycosyltransferases, like upper respiratory tract epithelial cells, we enrolled 290 patients with Covid-19 and 276 asymptomatic controls to compare their levels of natural ABO blood group antibodies.Results : We found significantly lower IgM anti-A + anti-B agglutination scores in blood group O patients (76.93 vs 88.29, P-value=0.034) and lower levels of anti-B (24.93 vs 30.40, P-value=0.028) and anti-A antibodies (28.56 vs 36.50, P-value= 0.048) in blood group A and blood group B patients, respectively, compared to controls.Conclusion : In this study, we showed that ABO antibodies levels are significantly lower in Covid-19 patients compared to controls. These findings could indicate that patients with low levels of ABO antibodies are at higher risk of being infected